XML 26 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
OPERATING ACTIVITIES        
Net income $ 8,762 $ 7,877 $ 25,495 $ 13,475
Adjustments to reconcile net income to net cash provided by operating activities:        
Equity in losses/(earnings) of associated companies 120 (90) 340 (98)
Depreciation 14,393 13,309 28,526 27,250
Amortization 2,312 2,276 4,489 4,230
Noncash interest expense 181 189 377 377
Provision for deferred income taxes, other credits and long-term liabilities 2,189 9,709 (24) 11,215
Provision for write-off of property, plant and equipment 23 1,626 64 3,093
Gain on disposition of assets (594)   (1,022)  
Decrease in cash surrender value of life insurance   847    
Excess tax benefit of options exercised (21)   (35)  
Compensation and benefits paid or payable in Class A Common Stock 950 2,054 1,290 3,009
Changes in operating assets and liabilities, net of business acquisitions and divestitures:        
Accounts receivable 5,049 (8,740) 6,905 (344)
Inventories (8,940) 9,748 (17,312) 12,018
Prepaid expenses and other current assets 797 739 (2,473) (2,030)
Accounts payable 1,654 (2,369) 3,902 (4,444)
Accrued liabilities 1,343 3,429 (4,090) (8,693)
Income taxes payable 1,161 1,758 4,859 321
Other, net 1,371 1,560 507 1,443
Net cash provided by operating activities 30,750 43,922 51,798 60,822
INVESTING ACTIVITIES        
Purchases of property, plant and equipment (8,975) (7,094) (13,894) (13,915)
Purchased software (705) (873) (1,752) (1,946)
Proceeds from sale of assets 1,159   2,860  
Acquisitions, net of cash acquired       (1,902)
Cash received from life insurance policy terminations   49,302   49,302
Net cash (used in)/provided by investing activities (8,521) 41,335 (12,786) 31,539
FINANCING ACTIVITIES        
Proceeds from borrowings 4   644 6,152
Principal payments on debt (980) (69,738) (7,997) (69,755)
Proceeds from options exercised 192 49 301 136
Excess tax benefit of options exercised 21   35  
Dividends paid (3,750) (3,714) (7,494) (7,419)
Net cash (used in) financing activities (4,513) (73,403) (14,511) (70,886)
Effect of exchange rate changes on cash and cash equivalents 1,812 (10,939) 10,244 (16,268)
Increase in cash and cash equivalents 19,528 915 34,745 5,207
Cash and cash equivalents at beginning of period 137,518 101,758 122,301 97,466
Cash and cash equivalents at end of period $ 157,046 $ 102,673 $ 157,046 $ 102,673